Overview: Plexus are partnered with a highly innovative vascular device company on a positive growth trajectory in Europe. We are seeking a driven Sales Manager for the DACH region to drive sales and expand market share
Transcatheter Mitral & Tricuspid Therapies (TMTTs) are the future of Edwards – Estimated to be a more than $5 billion opportunity by 2028, Edwards will discuss its multiple transcatheter programs aimed at transforming care for the
Innovation starts from the heart. At Edwards, we put patients first. We invest a significant proportion of our revenue towards research and development to drive and develop groundbreaking medical innovations for structural heart disease and critical